Adverse reactions and adherence to capecitabine: A prospective study in patients with gastrointestinal cancer.
Visacri MB, Duarte NC, Lima TM, de Souza RN, Cobaxo TS, Teixeira JC, Barbosa CR, Dias LP, Tavares MG, Pincinato EC, Lima CS, Moriel P.
Visacri MB, et al. Among authors: tavares mg.
J Oncol Pharm Pract. 2022 Mar;28(2):326-336. doi: 10.1177/1078155221989420. Epub 2021 Jan 20.
J Oncol Pharm Pract. 2022.
PMID: 33470162